People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| OrsoBio, Inc. | — | Biotechnology | Series C | $124.6M | $340.8M | 2023 |
| Nueva Bio LLC | — | Biotech / Pharma | Series B | $17.5M | $319.2M | 2022 |
| Sensearly Inc. | — | Biotechnology | Seed | $1.7M | $5.7M | 2025 |
Gangadhara Ganapati at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gangadhara Ganapati on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Srinivas Akkaraju | 1 | 10 |
| Matthew Young | 1 | 7 |
| Evan Rachlin | 1 | 3 |
| Muzammil Mansuri | 1 | 3 |
| Cory Freedland | 1 | 3 |
| Edward Fleming | 1 | 1 |
| Anita Mani Kohli | 1 | 1 |
| Tushar Deepak Chandra | 1 | 1 |
| G. Mani Subramanian | 1 | 1 |
| Mani Subramanian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.